Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain
about
Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans.The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.
P2860
Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@ast
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@en
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@nl
type
label
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@ast
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@en
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@nl
prefLabel
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@ast
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@en
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@nl
P2093
P2860
P3181
P1433
P1476
Trafficking Dynamics of PCSK9- ...... utations and C-Terminal Domain
@en
P2093
Annie Demers
Gaétan Mayer
Hocine Ait Hamouda
Louis Villeneuve
Steve Poirier
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0157230
P407
P577
2016-01-01T00:00:00Z